Splenic marginal zone lymphoma pathophysiology

Jump to navigation Jump to search

Splenic marginal zone lymphoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Splenic marginal zone lymphoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Biopsy

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Splenic marginal zone lymphoma pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Splenic marginal zone lymphoma pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Splenic marginal zone lymphoma pathophysiology

CDC on Splenic marginal zone lymphoma pathophysiology

Splenic marginal zone lymphoma pathophysiology in the news

Blogs on Splenic marginal zone lymphoma pathophysiology

Directions to Hospitals Treating Splenic marginal zone lymphoma

Risk calculators and risk factors for Splenic marginal zone lymphoma pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [5]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [6]

Overview

Genetics

  • Clonal rearrangements of the immunoglobulin genes (heavy and light chains) [1]
  • Deletion 7q21-32 is seen in 40% of SMZL patients
  • Translocations of the CDK6 gene located at 7q21 have also been reported[2]

Immunophenotype

Antigen Splenic marginal zone lymphoma

CD20

Positive

CD79a

Positive

CD5

Negative

CD10

Negative

CD23

Negative

CD43

Negative

cyclin D1

Negative

Microscopic Pathology

  • Splenic marginal zone lymphoma (SMZL) is a lymphoma comprised of B-cells that replace the normal architecture of the white pulp of the spleen.
  • The neoplastic cells are both small lymphocytes and larger, transformed blasts, and they invade the mantle zone of splenic follicles and erode the marginal zone, ultimately invading the red pulp of the spleen.
  • The neoplastic cells circulating in the peripheral blood are termed villious lymphocytes due to their characteristic appearance.[3]
  • Other features that may been seen include sinus invasion, epithelial histocytes, and plasmacytic differentiation of neoplastic cells.
  • Aside from the uniform involvement of the spleen, the bone marrow is frequently positive in patients with splenic marginal zone lymphoma. Nodal and extranodal involvement are rare.[3]
  • Splenic Hilar Lymph Nodes
  • Bone Marrow Biopsy
  • Splenic marginal zone lymphoma in bone marrow displays a nodular pattern with morphology similar to what is observed in the splenic hilar lymph nodes.[4]

References

  1. [1] Dunn-Walters DK, Boursier L, Spencer J, Isaacson PG. "Analysis of immunoglobulin genes in splenic marginal zone lymphoma suggests ongoing mutation." Hum Pathol. 1998 Jun;29(6):585-93. PMID: 9635678
  2. [2] Corcoran MM, Mould SJ, Orchard JA, Ibbotson RE, Chapman RM, Boright AP, Platt C, Tsui LC, Scherer SW, Oscier DG. "Dysregulation of cyclin dependent kinase 6 expression in splenic marginal zone lymphoma through chromosome 7q translocations." Oncogene. 1999 Nov 4;18(46):6271-7. PMID: 10597225
  3. 3.0 3.1 3.2 [3] Jaffe E.S., Harris N.L., Stein H., Vardiman J.W. (eds): World Health Organization Classification of Tumors. Pathology and Genetics of Tumours of Haemopoietic and Lymphoid Tissues. IARC Press: Lyon 2001
  4. [4] Franco V, Florena AM, Campesi G. "Intrasinusoidal bone marrow infiltration: a possible hallmark of splenic lymphoma." Histopathology. 1996 Dec;29(6):571-5. PMID: 8971565

Template:WH Template:WS